cutaneous leishmaniasis, american
Showing 1 - 4 of 4
Cutaneous Leishmaniasis, American Trial in Presidente Tancredo Neves (Oral tofacitinib, Parenteral meglumine antimoniate)
Not yet recruiting
- Cutaneous Leishmaniasis, American
- Oral tofacitinib
- Parenteral meglumine antimoniate
-
Presidente Tancredo Neves, Bahia, BrazilCorte de Pedra Health Post
Aug 21, 2023
Cutaneous Leishmaniasis, American Trial in Presidente Tancredo Neves (Sm29 Protein, Schistosoma Mansoni, Pentavalent antimony
Completed
- Cutaneous Leishmaniasis, American
- Sm29 Protein, Schistosoma Mansoni
- Pentavalent antimony (Sbv)
-
Presidente Tancredo Neves, Bahia, BrazilCorte de Pedra Health Post
Aug 17, 2023
Cutaneous Leishmaniasis, American Trial in Cali (Community based strategy to follow-up pactientes with Cutaneous Leishmaniasis)
Completed
- Cutaneous Leishmaniasis, American
- Community based strategy to follow-up pactientes with Cutaneous Leishmaniasis
-
Cali, Valle, ColombiaCorporación Centro Internacional de entrenamiento e Investigació
Sep 7, 2022
Cutaneous Leishmaniasis, American Trial in Jorochito (Miltefosine and Paromomycin, miltefosine, paromomycin)
Completed
- Cutaneous Leishmaniasis, American
- Miltefosine and Paromomycin
- +2 more
-
Jorochito, SC, BoliviaHopital, Dermatologico
Feb 1, 2021